Top

Published in:

01-06-2009 | Commentary

Broadening Research on Microfinance and Related Strategies for HIV Prevention: Commentary on Dworkin and Blankenship (2009)

Authors: Lance S. Weinhardt, Loren W. Galvão, Patricia E. Stevens, Winford H. Masanjala, Cecily Bryant, Thokozani Ng’ombe

Published in: AIDS and Behavior | Issue 3/2009

Excerpt

In their article, Microfinance and HIV/AIDS prevention: Assessing its promise and limitations, Dworkin and Blankenship (2009) provide a valuable introduction to microfinance as a structural HIV prevention approach and highlight its significance and limitations for women’s economic empowerment. Their overview of the components and types of microfinance programs is excellent. Their emphasis on the challenge to gender norms posed by woman-only projects is well taken. Gender power issues should clearly be integrated into future microfinance studies. Most importantly, their analysis contributes to a growing literature calling for HIV prevention efforts targeted to distal determinants of risk. …

Bertozzi, S. M., Laga, M., Bautista-Arredondo, S., & Coutinho, A. (2008). Making HIV prevention programmes work. Lancet, 372, 831–844. doi:10.1016/S0140-6736(08)60889-2.PubMedCrossRef

Black, N. (1996). Why we need observational studies to evaluate the effectiveness of health care. British Medical Journal, 312(7040), 1215–1218.PubMed

Bonnell, C., Hargreaves, J., Strange, V., Pronyk, P., & Porter, J. (2006). Should structural interventions be evaluated using RCTs? The case of HIV prevention. Social Science and Medicine, 63, 1135–1142. doi:10.1016/j.socscimed.2006.03.026.CrossRef

Coates, T. J., Richter, L., & Caceres, C. (2008). Behavioural strategies to reduce HIV transmission: How to make them work better. Lancet, 372, 669–684. doi:10.1016/S0140-6736(08)60886-7.PubMedCrossRef

Des Jarlais, D. C., Lyles, C., Crepaz, N., & TREND Group. (2004). Improving the reporting quality of nonrandomized evaluations and public health interventions: The TREND statement. American Journal of Public Health, 94, 361–366. doi:10.2105/AJPH.94.3.361.PubMedCrossRef

Dworkin, S. L., & Blankenship, K. (2009). Microfinance and HIV/AIDS prevention: assessing its promise and limitations. AIDS and Behavior. doi:10.1007/s10461-009-9532-3.

Glass, T. A., & McAtee, M. J. (2006). Behavioral science at the crossroads in public health: Extending horizons, envisioning the future. Social Science and Medicine, 62, 1650–1671. doi:10.1016/j.socscimed.2005.08.044.PubMedCrossRef

Gupta, G. R., Parkhurst, J. O., Ogden, J. A., Aggleton, P., & Mahal, A. (2008). Structural approaches to HIV prevention. Lancet, 372, 764–775. doi:10.1016/S0140-6736(08)60887-9.PubMedCrossRef

Merson, M. H., O’Malley, J., Serwadda, D., & Apisuk, C. (2008). The history and challenge of HIV prevention. Lancet, 372, 475–488. doi:10.1016/S0140-6736(08)60884-3.PubMedCrossRef

Pawson, R., Greenhalgh, T., Harvey, G., & Walshe, K. (2005). Realist review- a new method of systematic review designed for complex policy interventions. Journal of Health Services Research and Policy, 10(suppl 1), S1:21–S1:34.

Pronyk, J., Hargreaves, J., Kim, L., Morison, G., Phetla, C., Watts, J., et al. (2006). Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: A cluster randomised trial. Lancet, 368, 1973–1983. doi:10.1016/S0140-6736(06)69744-4.PubMedCrossRef

Victora, C. G., Habicht, J. P., & Bryce, J. (2004). Evidence-based public health: Moving beyond randomized trials. American Journal of Public Health, 94, 400–405. doi:10.2105/AJPH.94.3.400.PubMedCrossRef

West, S. G., Duan, N., Pequegnat, W., Gaist, P., Des Jarlais, D. C., Holtgrave, D., et al. (2008). Alternatives to the randomized controlled trial. American Journal of Public Health, 98, 1359–1366. doi:10.2105/AJPH.2007.124446.PubMedCrossRef

Title: Broadening Research on Microfinance and Related Strategies for HIV Prevention: Commentary on Dworkin and Blankenship (2009)
Authors: Lance S. Weinhardt
Loren W. Galvão
Patricia E. Stevens
Winford H. Masanjala
Cecily Bryant
Thokozani Ng’ombe
Publication date: 01-06-2009
Publisher: Springer US
Published in: AIDS and Behavior / Issue 3/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-009-9561-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2009

Pilot Trial of an Intervention Aimed at Modifying Drug Preparation Practices Among Injection Drug Users in Puerto Rico

HIV Sexual Risk Behavior by Men Who use the Internet to Seek Sex with Men: Results of the Men’s INTernet Sex Study-II (MINTS-II)

Common Factors in Effective HIV Prevention Programs

Effects of an Internet-Based Intervention for HIV Prevention: The Youthnet Trials

Family Wellness, Not HIV Prevention

A Review of HIV/AIDS System-Level Interventions

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials